Moderna (MRNA.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Quote List Quote List

Event Tracking

Dec26

Moderna's stock price increase leads to an upgrade in IBD Relative Strength Rating

20:21

Dec25

Corient Private Wealth LLC Increases Holdings in Moderna

08:40

Dec18

Moderna Receives CEPI Support for mRNA Avian Flu Vaccine Development

12:00

Dec17

Moderna Inc. to Attend the 44th J.P. Morgan Healthcare Conference

12:00

Dec15

Noubar Afeyan Sells Shares of Moderna Inc.

14:00

Moderna's COVID-19 Vaccine Receives CHMP Market Authorization Recommendation

12:01

Schedules & Filings

Schedules

Filings

Nov6

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 1.016 B, Net Income -200 M, EPS -0.5128

Moderna, Inc. (MRNA.US) Q3 2025 Earnings Conference Call

Aug1

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 142 M, Net Income -825 M, EPS -2.1262

May1

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 108 M, Net Income -971 M, EPS -2.5155

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change